Stocks
Anika Therapeutics (ANIK) EBITDA margin US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -2.82% | 16.0% | 12.5% | 2.52% | -3.17% | -5.70% | ||
| Changes by years, y/y, % | -2pp | +19pp | -3pp | -10pp | -6pp | +32.7% | |||
Anika Therapeutics. EBITDA margin, %
Anika Therapeutics. EBITDA margin, changes, pp
Anika Therapeutics (ANIK) EBITDA margin US GAAP (quarter values) |
||||||||
| FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | FY2026Q2 | LTM ? | |||
| EBITDA margin, % | ? | -8.74% | -3.01% | 6.80% | -11.5% | 15.0% | -5.70% | |
| Changes by years, y/y, % | -10pp | +63pp | -2 050pp | -1pp | +24pp | |||
| Changes by quarters, q/q, % | +2pp | +6pp | +10pp | -18pp | +27pp | |||
